Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of90Y-DOTA-peptide-Lym-1 in lymphoma xenografts

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

1949 • 19,979 citations

The JNK signal transduction pathway

2002 • 1,520 citations

Adjuvant Therapy for Patients With Colon and Rectal Cancer

1990 • 1,047 citations

Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma

1998 • 1,010 citations

The Role of c-Jun N-terminal Kinase (JNK) in Apoptosis Induced by Ultraviolet C and γ Radiation

1996 • 881 citations

Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support

1993 • 665 citations

Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20⁺B-Cell Non-Hodgkin's Lymphoma

1999 • 563 citations

Radioimmunotherapy of B-Cell Lymphoma with [¹³¹I]Anti-B1 (Anti-CD20) Antibody

1993 • 557 citations

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas

1995 • 447 citations

Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C

1991 • 445 citations

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma.

1996 • 410 citations

Targeted therapy of cancer with radiolabeled antibodies.

2002 • 322 citations

Chemotherapy plus Radiotherapy Compared with Radiotherapy Alone in the Treatment of Locally Advanced, Unresectable, Non-Small-Cell Lung Cancer

1996 • 271 citations

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.

1998 • 189 citations

Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma.

1999 • 120 citations

Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: Efficacy and toxicity in breast cancer xenografts

1997 • 112 citations

Fractionated radioimmunotherapy of B-cell malignancies with 131I-Lym-1.

1990 • 111 citations

CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor

1998 • 106 citations

Low-dose, Fractionated Radioimmunotherapy for B-cell Malignancies using¹³¹I-LYM-1 Antibody

1998 • 97 citations

CD19, CD21, and CD22: Multifaceted Response Regulators of B Lymphocyte Signal Transduction

2001 • 95 citations

The role of the stress-activated protein kinase (SAPK/JNK) signaling pathway in radiation-induced apoptosis

1998 • 91 citations

Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation

1996 • 83 citations

Involvement of p72syk kinase, p53/561yn kinase and phosphatidyl inositol‐3 kinase in signal transduction via the human B lymphocyte antigen CD22

1996 • 82 citations

CD22 Cross-Linking Generates B-Cell Antigen Receptor-Independent Signals That Activate the JNK/SAPK Signaling Cascade

1999 • 82 citations

Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus.

1997 • 74 citations

67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma.

1999 • 64 citations

Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer.

1997 • 62 citations

Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study.

1998 • 61 citations

Comparative toxicity studies of yttrium-90 mx-dtpa and 2-it-bad conjugated monoclonal antibody (bre-3)

1994 • 59 citations

Neovascular Targeting with Cyclic RGD Peptide (cRGDf-ACHA) to Enhance Delivery of Radioimmunotherapy

2000 • 56 citations

Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies

2002 • 54 citations

Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10

1996 • 53 citations

Prevention of Anti-IgM-Induced Apoptosis Accompanying G1 Arrest in B Lymphoma Cells Overexpressing Dominant-Negative Mutant Form of c-Jun N-Terminal Kinase 1

2001 • 51 citations

Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji).

1997 • 45 citations

New developments in monoclonal antibodies for cancer detection and therapy

1994 • 44 citations

Overview of radiation myelotoxicity secondary to radioimmunotherapy using131 i-lym-1 as a model

1994 • 40 citations

Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

1999 • 39 citations

A phase I study of 90Y-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma.

2001 • 38 citations

Regulation of MHC Class II Signal Transduction by the B Cell Coreceptors CD19 and CD22

2000 • 37 citations

Update: A Revolution in the Treatment of Non-Hodgkin's Lymphoma

1998 • 36 citations

Dose Escalation of Radioantibody in a Mouse Model With the Use of Recombinant Human Interleukin-1 and Granulocyte-Macrophage Colony-Stimulating Factor Intervention to Reduce Myelosuppression

1992 • 33 citations

Receptor Modulators of B-Cell Receptor Signalling — CD19/CD22

2000 • 31 citations

Combined Modality Radioimmunotherapy with Taxol and ⁹⁰Y-LYM-1 for Raji Lymphoma Xenografts

1998 • 30 citations

Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol.

1999 • 27 citations

Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts.

1998 • 23 citations

Fractionated intravenous administration of 90Y-labeled B72.3 GYK-DTPA immunoconjugate in beagle dogs

1993 • 21 citations

Chemoradiotherapy in non-small cell lung cancer: paclitaxel/carboplatin/radiotherapy in regionally advanced disease.

1996 • 19 citations

Pharmacokinetics and biodistribution of radioimmunoconjugates of anti-CD19 antibody and single-chain Fv for treatment of human B-cell Malignancy

1998 • 17 citations

Radioimmunotherapy of the non-Hodgkin's lymphomas

1995 • 11 citations